Augmentation of host defense against bacterial infection pretrfatjd intraperitony with an αglucan RBS in mice

Yasuyuki Takeda, Yasunobu Yoshikai, Shouichi Ohga, Kikuo Nomoto

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Protection against Listeria mnocytogenes and Escherichia coli in mice was enhanced by an intraperitoneal (i.p.) administration of plysaccharide "RBS" Eritoneal macrophages from mice adrmnistered i.p. with 30 mg/kg doses of RBS 4 days earlier exhibited increased scavenger functions as assessed by in vivo phagocytosis, in vitro intracellular killing and generation of superoxide anion. When cytokine production of the macrophages was assessed by biological assay and Northern blotting analysis, interleukin (IL)-l production and IG-1α gene expression were significantly increased in macrophages from RBS-treated mice. 01 the other hand, tumor necrosis factor (TNF)α gene was expressed in macrophages from RBS-treated mice at a much reduced level as compared with those in mice treated i.p. with Corynebacterium parvum on 4 days earlier. In correlation with expression of TNF gene in the mcrophages, RBS-treated mice were less susceptible to the lethal toxicity of LPS than C. parvum-treated mice. In RBS-treated mice, in vivo elimination of bacteria was enhanced at the early phase of infection with L. monocytogenes or E. coli, resulting in augmentation of host defense against these bacterial infection. These results suggest that adequately enhanced activities of macrophages acting as scavenger phasocytes play important roles in the enhanced resistance against bacteria in mice treated i.p. with RBS.

Original languageEnglish
Pages (from-to)457-477
Number of pages21
JournalImmunopharmacology and Immunotoxicology
Volume12
Issue number3
DOIs
Publication statusPublished - Jan 1 1990

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Toxicology
  • Pharmacology

Cite this